34D.F 104.1 (-0.72%)
IT0003492391Medical Diagnostics & ResearchDiagnostics & Research

Diasorin (34D.F) Stock Highlights

104.1 | -0.72%
2024-10-22 00:38:37
DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics--testing done on samples taken from the human body, such as blood and issue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (55% of sales) and molecular diagnostics (35%) and has a total installed base of over 9,000 diagnostic systems. Licensed technologies contribute the remaining 10% of total sales, DiaSorin has a strong presence in Europe, the Middle East, and Africa; the region accounts for the largest portion of company revenue (44%), followed by North America (41%), Asia-Pacific (11%), and Latin America (4%).

Statistics

Range Today
104.1 104.1
Volume Today 30
Range 1 Year
80.98 105.6
Volume 1 Year 2.49K
Range 3 Year
80.98 196.2
Volume 3 Year 6.21K
Range 10 Year
27.971 211
Volume 10 Year 65.37K

Highlights

Market Capitalization 6.21B (mid)
Floating Shares 21.12M
Current Price 104.1
Price To Earnings 34.6
Price To Revenue 5.51
Price To Book 3.46
Earnings Per Share 3.03
Dividend Yield 1.12%
Dividend Per Share 1.15
Payout Ratio 37.95%

Performance

Latest -0.72%
1 Month +1.41%
3 Months +1.26%
6 Months +14.22%
1 Year +27.14%
3 Years -43.55%
5 Years +5.47%
10 Years +272.17%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.